India  

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

DNA Saturday, 14 November 2020
SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
0
shares
ShareTweetSavePostSend
 
Video Credit: PA - Press Association STUDIO - Published
News video: Hancock: UK will have access to five million doses of Moderna vaccine if it is approved

Hancock: UK will have access to five million doses of Moderna vaccine if it is approved 01:29

The UK will have access to five million doses of the Moderna vaccine if it isapproved, Matt Hancock announced. The firm has claimed a 94.5% effectivenessagainst the illness for the vaccine, although it is not expected to beavailable in the UK before spring 2021.

💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

No application received from SII for EU authorisation of Covishield vaccine: EMA

Poonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.
DNA
Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News [Video]

Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News

Today, the health ministry said that the predictions about the third wave of Covid should be taken very seriously; Sources in the Serum Institute of India said that the production of Covishield has been ramped up to around 110 million doses this month; Today, the Finance Ministry said that keeping in mind the growing demand for holding clerical cadre examinations in public sector banks in local or regional languages, a committee has been formed to look into the matter; Today, Congress slammed the Centre over the surge of prices of petrol and diesel in the country. #CovidThirdWave #Predictions #CovidNorms

Credit: Oneindia    Duration: 02:37Published
India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia [Video]

India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia

Serum Institute of India's Covishield vaccine has been approved in seven European Union nations and Switzerland amid a row over travel pass. Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are confirmed as including Covishield. #EU #Covidshield #Covid19

Credit: Oneindia    Duration: 02:02Published
SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News [Video]

SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News

The Subject Expert Committee of the Central Drugs Standard Control Organisation did not approve Serum Institute of India’s request to allow clinical trials of its second Covid vaccine in children. #SII #CDSCO #Covovax

Credit: Oneindia    Duration: 01:31Published

Adar Poonawalla Adar Poonawalla Indian businessman

Adar Poonawalla assures Covidshield-vaccinated Indians facing issues with EU travel| Oneindia News [Video]

Adar Poonawalla assures Covidshield-vaccinated Indians facing issues with EU travel| Oneindia News

Serum Institute CEO Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the drug. Poonawalla said he had taken this up at the highest levels" and that he hoped the matter would be resolved soon. #AdarPoonawalla #Covidshield #EUTravel

Credit: Oneindia    Duration: 02:01Published
Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News [Video]

Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News

A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has been filed at Aashiana police station in Lucknow. Meanwhile, the complainant has threatened to move court if an FIR is not registered against the people mentioned in his complaint. #AdarPoonawalla #Covidshield #SerumInstitute

Credit: Oneindia    Duration: 01:48Published

Novavax Novavax American biotechnology company

Serum Institute begins production of Novavax | 50 cases of Delta Plus in India | Oneindia News [Video]

Serum Institute begins production of Novavax | 50 cases of Delta Plus in India | Oneindia News

Union Minister for IT Ravi Shankar Prasad tweeted that the microblogging platform had denied him access to his account arbitrarily; As many as 48 coronavirus cases of Delta Plus variant have been detected from 45,000 samples sequenced so far in India; The Serum Institute of India said that it has started production of the Covid-19 vaccine developed by Novavax. All this and morenews at 9 PM. #RaviShankarPrasad #Novavax #DeltaPlus

Credit: Oneindia    Duration: 03:02Published
Covid19: Serum Institute of India to start trials of Novavax vaccine for kids in July| Oneindia News [Video]

Covid19: Serum Institute of India to start trials of Novavax vaccine for kids in July| Oneindia News

The Serum Institute of India (SII) hopes to start the clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July. The SII is also planning to introduce 'Covovax' its version of the US firm Novavax's vaccine candidate in India by September. Last year in September, Novavax had announced a manufacturing agreement with SII for its Covid-19 vaccine. #Novavax #ClinicalTrialsInKids #Covid19

Credit: Oneindia    Duration: 01:47Published
Novavax vaccine over 90% effective in U.S. trial [Video]

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer McCarthy reports.

Credit: Reuters - Politics    Duration: 01:41Published
Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial [Video]

Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial

Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial

Credit: ABC Action News    Duration: 01:53Published

AstraZeneca British-Swedish pharmaceutical company

Why the risk-benefit balance of AstraZeneca jab for young people has shifted

The risks posed by the Oxford-AstraZeneca vaccine to young adults in their 20s and 30s may now be outweighed by its benefits, according to the calculus used by..
Sky News
Pfizer, AstraZeneca full course is effective against Delta variant: Study | Oneindia News [Video]

Pfizer, AstraZeneca full course is effective against Delta variant: Study | Oneindia News

A study published on Wednesday has shown that 2 doses of the Pfizer or the AstraZeneca vaccine is effective against the Delta variant of the Coronavirus too. #AstraZeneca #Covaxin #Pfizer

Credit: Oneindia    Duration: 02:00Published
French Government allows Covishield-jabbed travellers into the country | AstraZeneca | Oneindia News [Video]

French Government allows Covishield-jabbed travellers into the country | AstraZeneca | Oneindia News

From today, France will allow international travellers who have had AstraZeneca’s Indian-manufactured vaccine into the country. Covishield is being accepted all across the world. #Covishield #France #SII

Credit: Oneindia    Duration: 01:39Published

France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countries

The European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel
DNA

You Might Like


Related videos from verified sources

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO [Video]

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO

The CEO of India's Serum Institute says India will get supplies of the Oxford-AstraZeneca vaccine that his organisation produces, first.

Credit: Newsflare STUDIO     Duration: 01:28Published
‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla [Video]

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla

Serum Institute India CEO Adar Poonawalla spoke on Prime Minister Narendra Modi’s visit to vaccine lab in Pune. Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and..

Credit: HT Digital Content     Duration: 04:05Published
COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India [Video]

COVID-19 vaccine will be distributed initially in India: CEO Serum Institute of India

COVID-19 vaccine will be distributed initially in India, informed Chief executive officer (CEO) of Serum Institute of India, Adar Poonawalla on November 28. He said, "Vaccine will be distributed..

Credit: ANI     Duration: 01:25Published

Related news from verified sources

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

Vaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian...
IndiaTimes Also reported by •Zee News

India could get access to AstraZeneca vaccine by January, says local manufacturer


IndiaTimes Also reported by •Mid-Day

SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla

The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and...
Mid-Day Also reported by •IndiaTimesHindu